NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Stride, Inc. (“Stride” or the “Company”) (NYSE: LRN) for violations of the federal securities laws on behalf of investors who purchased or acquired Stride securities between October 22, 2024 and October 28, 2025, inclusive (the “Class Period”). On November 11, 2025, a complaint was filed against the Company and certa ...

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Primo Brands Corporation (“Primo Brands” or the “Company”) (NYSE: PRMB) for violations of the federal securities laws on behalf of investors who purchased or acquired (i) the common stock of Primo Water Corporation between June 17, 2024 through November 8, 2024, inclusive, and/or (ii) the common stock of Primo Brands ...

Core Viewpoint - A class action lawsuit has been filed against Jayud Global Logistics Ltd. for allegedly misleading investors during the Class Period from April 21, 2023, to April 30, 2025, with a deadline for lead plaintiff applications set for January 20, 2026 [2][6]. Group 1: Lawsuit Details - The lawsuit claims that Jayud was involved in a fraudulent stock promotion scheme that included misinformation on social media and impersonation of financial professionals [6]. - It is alleged that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign [6]. - The company's public statements and risk disclosures reportedly failed to mention the false rumors and artificial trading activity affecting the stock price, leading to materially misleading statements about its business and prospects [6]. Group 2: Investor Guidance - Investors who purchased Jayud securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - To join the class action, investors can visit the provided link or contact the law firm directly for more information [4][7]. - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [5].

Core Viewpoint - WPP plc is facing a class action lawsuit due to allegations of misleading statements regarding its expected revenue for fiscal year 2025, which led to significant financial losses for investors [5][6]. Group 1: Legal Action and Investor Information - Faruqi & Faruqi, LLP is investigating potential claims against WPP and reminds investors of the December 8, 2025 deadline to seek the role of lead plaintiff in the class action lawsuit [2]. - Investors who purchased WPP securities between February 27, 2025, and July 8, 2025, are encouraged to contact the law firm to discuss their legal rights [1][2]. Group 2: Allegations Against WPP - The complaint alleges that WPP and its executives violated federal securities laws by making false and misleading statements about the company's media division and its ability to handle macroeconomic challenges [5]. - WPP's executives claimed that new business wins would offset losses, while concealing the true state of the media arm, which was losing market share [5]. Group 3: Market Reaction - Following WPP's trading update on July 9, 2025, which indicated a deterioration in performance, the company's stock price fell from $35.82 to $29.34, a decline of approximately 18.1% in one day [6][7].

Core Viewpoint - Baxter International Inc. is facing a federal securities class action lawsuit due to allegations of making false statements regarding the safety and efficacy of its Novum LVP product, which has been linked to serious patient risks [5][6]. Group 1: Legal Action and Investor Information - Faruqi & Faruqi, LLP is investigating potential claims against Baxter and reminds investors of the December 15, 2025 deadline to seek the role of lead plaintiff in the class action lawsuit [2]. - Investors who suffered losses from Baxter's securities between February 23, 2022, and July 30, 2025, are encouraged to contact the law firm to discuss their legal rights [1][2]. Group 2: Allegations Against Baxter - The complaint alleges that Baxter and its executives violated federal securities laws by failing to disclose systemic defects in the Novum LVP, which caused malfunctions and posed risks of serious injury or death to patients [5]. - Baxter was reportedly aware of multiple device malfunctions, injuries, and deaths related to the Novum LVP but did not take adequate remedial measures [5]. - Following the announcement on July 31, 2025, regarding the voluntary pause of shipments and installations of the Novum LVP, Baxter's stock price dropped by 22.4%, closing at $21.76 [6][7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against James Hardie Industries plc for misleading investors regarding the performance of its North America Fiber Cement segment, with a class action lawsuit deadline set for December 23, 2025 [2][5]. Group 1: Legal Action and Investor Information - Investors who suffered losses exceeding $100,000 in James Hardie between May 20, 2025, and August 18, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal options [1]. - A federal securities class action has been filed against James Hardie, with a deadline for seeking the role of lead plaintiff on December 23, 2025 [2]. - The lead plaintiff in a class action is typically the investor with the largest financial interest who directs the litigation on behalf of the class [7]. Group 2: Allegations Against James Hardie - The complaint alleges that James Hardie and its executives violated federal securities laws by making false statements and failing to disclose the true state of its North America Fiber Cement segment [5]. - Despite knowing about inventory destocking by distributors, James Hardie falsely claimed that demand remained strong and stock levels were normal [5]. - Following the announcement of a 29% decline in first-quarter profit and lower-than-expected fiscal 2026 earnings, James Hardie's ADR price fell by $9.79, or 34.44%, closing at $18.64 on August 20, 2025 [6].

Core Points - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of securities of Jayud Global Logistics Ltd. for the period between April 21, 2023, and April 30, 2025 [1] - Investors who purchased Jayud securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A lead plaintiff must move the Court by January 20, 2026, to represent other class members in the litigation [3] Case Details - The lawsuit alleges that Jayud made materially false and misleading statements and failed to disclose critical information, including involvement in a fraudulent stock promotion scheme and insider trading activities [5] - Specific allegations include the use of social media misinformation, offshore accounts for share dumping, and omission of false rumors affecting stock prices [5] Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as Rosen Law Firm has achieved significant settlements in the past [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Molina Healthcare, Inc. for alleged violations of federal securities laws, encouraging affected investors to participate in a class action lawsuit [2][5]. Summary by Sections Legal Action - Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, may have the opportunity to lead a class action lawsuit against the company [1][2]. - The deadline to seek the role of lead plaintiff in the federal securities class action is December 2, 2025 [2]. Allegations Against Molina - The complaint alleges that Molina and its executives made false or misleading statements regarding: 1. Material adverse facts about the company's medical cost trend assumptions [5]. 2. A dislocation between premium rates and medical cost trends [5]. 3. Dependency on low utilization of behavioral health, pharmacy, and inpatient and outpatient services for near-term growth [5]. 4. Likelihood of substantial cuts to financial guidance for fiscal year 2025 [5]. 5. Misleading positive statements about the company's business and operations [5]. Financial Performance - On July 7, 2025, Molina announced second-quarter financial results, revealing adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures [6][7]. - The company cut its full-year 2025 adjusted earnings per share guidance by 10.2%, from at least $24.50 to a range of $21.50 to $22.50 [7]. - Following this announcement, Molina's stock price fell by $6.97, or 2.9%, closing at $232.61 per share [7]. - On July 23, 2025, Molina further reduced its full-year 2025 earnings guidance, reporting GAAP net income of $4.75 per diluted share for the second quarter, an 8% decrease year over year [8]. - The new guidance for full-year 2025 adjusted earnings was set at no less than $19.00 per diluted share, reflecting a 13.6% cut from previous guidance [8]. - Molina's stock price dropped by $32.03, or 16.84%, closing at $158.22 per share following this announcement [8].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against WPP plc due to allegations of false and misleading statements regarding the company's expected revenue for fiscal year 2025, which may have led to significant financial losses for investors [6][8]. Group 1: Legal Investigation and Class Action - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in WPP to contact them for discussing legal options, particularly regarding a federal securities class action with a deadline of December 8, 2025, to seek the role of lead plaintiff [3][10]. - The firm has a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [5]. Group 2: Allegations Against WPP - The complaint alleges that WPP and its executives violated federal securities laws by making false statements and failing to disclose material information about the company's media division and its ability to handle macroeconomic challenges [6][9]. - WPP's stock price experienced a significant decline of approximately 18.1%, dropping from $35.82 per share on July 8, 2025, to $29.34 per share on July 9, 2025, following the company's trading update that indicated a deterioration in performance [9]. Group 3: Company Performance and Market Reaction - WPP's trading update on July 9, 2025, revealed a decline in performance attributed to macroeconomic uncertainties and weaker new business, which was compounded by ongoing restructuring efforts within the company [8][9]. - The company's optimistic statements about revitalizing its media division and retaining clientele were contradicted by the actual performance and market share losses [6].

Core Viewpoint - Firefly Aerospace is facing a class action lawsuit due to allegations of misleading statements regarding its business operations and financial performance, particularly related to its IPO and subsequent financial results [5][2]. Group 1: Legal Actions and Investigations - Faruqi & Faruqi, LLP is investigating potential claims against Firefly Aerospace and has announced a deadline of January 12, 2026, for investors to seek the role of lead plaintiff in the class action lawsuit [2]. - The lawsuit alleges that Firefly and its executives violated federal securities laws by making false statements about the demand for its Spacecraft Solutions and the operational readiness of its Alpha rocket program [5][6]. Group 2: Financial Performance - Firefly conducted its IPO on August 7, 2025, selling 19.296 million shares at $45.00 per share [6]. - In its first earnings report as a public company on September 22, 2025, Firefly reported a loss of $80.3 million, or $5.78 per share, compared to a loss of $58.7 million, or $4.60 per share, in the same quarter of 2024 [7]. - Revenue for the second quarter of 2025 was reported at $15.55 million, which was below analyst estimates of $17.25 million and represented a 26.2% decrease year-over-year [7]. Group 3: Stock Price Reactions - Following the earnings report, Firefly's stock price fell by $7.58 per share, or 15.31%, closing at $41.94 on September 23, 2025 [8]. - After the disclosure of a failed rocket stage on September 29, 2025, the stock price dropped further by $7.66 per share, or 20.73%, closing at $29.30 on September 30, 2025 [10].